The New York Blood Center (NYBC) opened its first-ever donor center based in Queens, marking a milestone for the organization ...
Bavier joins Sudo from norovirus vaccine developer HilleVax, where he was GC and chief administrative officer. He brings more ...
Christie Innomed Inc., a leader in medical imaging and health technologies, announces that Dr. Michel Vachon and Nicolas Vachon have acquired all the shares of Group Christie and its subsidiaries.
Trust AI announced today that Isaac OneHealth, the clinical AI platform transforming dental practice, has achieved a perfect 100% score on the most challenging questions from the United States Medical ...
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
AN ENLIGHTENING session, entitled ‘Emerging therapeutic frontiers in cardiology: what does the future hold?’, delivered at ...
Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...
Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
They manage to slow down the progression of Huntington's disease using a gene therapy treatment called AMT 130.
A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback